Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations

The introduction of Direct Oral Anticoagulants (DOACs) to the pharmaceutical market provided patients and clinicians with novel convenient and safe options of anticoagulation. The use of this class of medications is currently limited to venous thromboembolic therapy and prophylaxis, in addition to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhosseiny, Sherif, Al Moussawi, Hassan, Chalhoub, Jean M., Lafferty, James, Deeb, Liliane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354142/
https://www.ncbi.nlm.nih.gov/pubmed/30792971
http://dx.doi.org/10.1155/2019/4383269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354142/
https://www.ncbi.nlm.nih.gov/pubmed/30792971
http://dx.doi.org/10.1155/2019/4383269

Ejemplares similares